AMRX icon

Amneal Pharmaceuticals
AMRX

Overview Fund Activity

144 hedge funds and large institutions have $430M invested in Amneal Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
144
Holders Change
+16
Holders Change %
+12.5%
% of All Funds
2.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
54
Reduced
32
Closed
15
Calls
$668K
Puts
$8K
Net Calls
+$660K
Net Calls Change
+$447K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$11.3M
2
RCMNY
2
Rubric Capital Management (New York)
New York
$17M
3
Nuveen Asset Management
3
Nuveen Asset Management
Illinois
$7.81M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$8.34M
5
Russell Investments Group
5
Russell Investments Group
United Kingdom
$3.18M

Top Sellers

1
EP
1
Eversept Partners
New York
$11.2M
2
AQR Capital Management
2
AQR Capital Management
Connecticut
$3.97M
3
Allspring Global Investments
3
Allspring Global Investments
North Carolina
$1.2M
4
Millennium Management
4
Millennium Management
New York
$3.09M
5
Deutsche Bank
5
Deutsche Bank
Germany
$248K
Name Holding Trade Value Shares
Change 		Shares
Change %
Grantham, Mayo, Van Otterloo & Co (GMO)
151
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
– -$71.6K -23,100 Closed
SFI
152
Susquehanna Fundamental Investments
Pennsylvania
– -$52.9K -17,064 Closed
VFA
153
Virtus Fund Advisers
Connecticut
– -$21.5K -6,941 Closed
Group One Trading
154
Group One Trading
Illinois
– -$2.73K -880 Closed
Simplex Trading
155
Simplex Trading
Illinois
– -$1K -430 Closed
DA
156
Denali Advisors
California
– -$1.05K -337 Closed
QT
157
Quantbot Technologies
New York
– -$3 -1 Closed
3 4 5 6
7